Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve inter alia, the following: Un-audited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Decipher Labs Ltd (formerly Combat Drugs Limited) has informed the BSE that its Board of Directors will meet on Thursday, 14 August 2025, at the company's registered office in Hyderabad. The main item on the agenda is to consider and approve the un-audited financial results (both standalone and consolidated) for the quarter ended 30 June 2025, which is Q1 of FY26. The board will also take on record the Limited Review Report from the auditors for the same period. No financial numbers, profit/loss figures, or revenue details have been shared in this filing — these will only be disclosed after the board meeting is held. The filing was signed by Non-Executive Director Sushant Mohan Lal on 11 August 2025, and was made under SEBI's Listing Obligations and Disclosure Requirements rules.
This is a routine advance notice required by stock exchange rules before a company announces its quarterly earnings. No actual results or numbers have been disclosed yet, so there is no direct impact on the stock price from this filing alone. Retail investors should wait for the actual Q1 FY26 results on or after 14 August 2025 to assess the company's performance and make investment decisions.